Tag «Lazcluze»

lazertinib

It’s only fair to share…   lazertinib CAS 1903008-80-9  554.655, C30H34N8O3 2-PROPENAMIDE, N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)-2-PYRIMIDINYL)AMINO)-4-METHOXY-2-(4-MORPHOLINYL)PHENYL)- N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)AMINO)-4-METHOXY-2-MORPHOLINOPHENYL)ACRYLAMIDE C-18112003-G GNS 1480 GNS-1480 GNS1480 JNJ-73841937-AAA YH 25448 YH-25448 YH25448 FDA APPROVED  8/19/2024 To treat non-small cell lung cancer, Lazcluze Ingredient UNII CAS InChI Key Lazertinib mesylate monohydrate WUT449BEG5 2411549-88-5 ZJPNGZUERUYZEG-UHFFFAOYSA-N Lazertinib is an oral, third-generation, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor …